Teva Pharmaceuticals Europe B.V.

GPTKB entity

Properties (107)
Predicate Object
gptkbp:instanceOf gptkb:Company
gptkbp:acquisition Cephalon
Actavis Generics
Allergan's generics business
gptkbp:awards Innovation Award 2020
Sustainability Award 2019
Best Employer Award 2021
Pharma_Company_of_the_Year_2020
Best_Workplace_in_Europe_2021
gptkbp:corporateSocialResponsibility Community engagement
Sustainability initiatives
Employee well-being
Access to medicines
gptkbp:employs thousands of employees
gptkbp:focus Multiple sclerosis
Oncology
Pain management
Autoimmune diseases
Neurology
Respiratory
gptkbp:focusesOn neurology
oncology
pain management
respiratory diseases
gptkbp:founded 1901
gptkbp:foundedIn 1901
gptkbp:founder Salomon_Steinberg
gptkbp:hasProductLine gptkb:Metformin
gptkb:Simvastatin
Lisinopril
Fexofenadine
Ciprofloxacin
Levothyroxine
Duloxetine
Breztri Aerosphere
Diphenhydramine
Budesonide
Fluticasone
Mometasone
Procrit
Aripiprazole
Bupropion
Escitalopram
Quetiapine
Risperidone
Sertraline
Venlafaxine
Ipratropium
Ajovy
Atorvastatin
Omeprazole
Copaxone
Clonazepam
Gabapentin
Montelukast
Alprazolam
Buspirone
Diazepam
Hydroxyzine
Lorazepam
Promethazine
Austedo
Beclomethasone
Cetirizine
Ciclesonide
Fentanyl Transdermal System
Formoterol
Levocetirizine
Qvar
Theophylline
Tiotropium
Trisenox
Vantrela ER
Zecuity
Salmeterol
Zafirlukast
gptkbp:hasSubsidiary gptkb:Teva_UK_Limited
Teva_France_S.A.S.
Teva_Germany_GmbH
Teva_Italy_S.r.l.
Teva_Spain_S.L.
gptkbp:headquarteredIn gptkb:Amsterdam
gptkbp:headquarters Amsterdam,_Netherlands
https://www.w3.org/2000/01/rdf-schema#label Teva Pharmaceuticals Europe B.V.
gptkbp:industry Pharmaceuticals
gptkbp:numberOfEmployees Approximately 40,000
gptkbp:offers generic drugs
specialty medicines
gptkbp:operatesIn Europe
gptkbp:parentCompany gptkb:Teva_Pharmaceutical_Industries_Ltd.
gptkbp:partnerships Partnership with Pfizer
Partnership with Sanofi
Partnership with Takeda
Partnership with Merck
Partnership_with_Procter_&_Gamble
gptkbp:products Specialty medicines
Generic_drugs
gptkbp:researchAndDevelopment Focus on complex generics
Focus on biosimilars
Focus on innovative medicines
gptkbp:revenue $16.7 billion (2020)
gptkbp:subsidiary gptkb:Teva_UK_Limited
Teva Italia S.r.l.
Teva_France_S.A.S.
Teva_Germany_GmbH
Teva_Spain_S.L.
gptkbp:website www.tevapharm.com